Log in Get started

Series

The T Files S5 — The cardiovascular scare

The 2010 study that scared everyone, the flawed meta-analysis behind the FDA warning, and how TRAVERSE finally answered the question.

Parts: 5
By: Keen Clinician Team

Read in order

1. The Trial That Was Stopped Early Because the Treated Group Had More Cardiac Events

2. How Three Years of Contested Evidence Became a Warning on Every Label

3. 5,204 Men, All at Cardiovascular Risk, Randomised to Testosterone or Placebo

4. Low Testosterone Tracks With Heart Disease. That Was Never the Same as Causing It.

5. What Actually Changed After TRAVERSE — and What Didn't

Feel like yourself again.

Get started See how it works